IONIS PHARMACEUTICALS, INC. 10-K 12-31-2024

Company

IONIS PHARMACEUTICALS INC

Filed

February 19, 2025

Period of Report

December 31, 2024

Accession Number

0000874015-25-000089

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →